Glonway, July 13, 丨 ① Leadman: The company recently obtained a new “Medical Device Registration Certificate” for a fully automated chemiluminescence immunoanalyzer issued by the Beijing Drug Administration. ② Longyuan Technology: It is estimated that the net profit of Guimu in the first half of the year will be 5 million yuan to 6 million yuan, down 91.54%-92.95% from the previous year. ③ Sunflower Pharmaceutical: The net profit for the first half of the year is estimated to be 600 million yuan to 660 million yuan, an increase of 49.54%-64.50% over the previous year. During the reporting period, the company's drug categories for children and drugs for adults showed an increasing trend. ④ Huang Shanghuang: Issuing shares to specific targets has been approved by the Shenzhen Stock Exchange Listing Review Center.